Checkpoint Responses in Cancer Therapy

1. RB-Pathway
Erik S. Knudsen, Wesley A. Braden

2. Targeting the p53/MDM2 Pathway for Cancer Therapy
Christian Klein, Lyubomir T. Vassilev

3. DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer
Ryan P. Bender, Neil Osheroff

4. Targeting ATM/ATR in the DNA Damage Checkpoint
Joseph M. Ackermann, Wafik S. El-Deiry

5. Compounds that Abrogate the G2 Checkpoint
Takumi Kawabe

6. CDK Inhibitors as Anticancer Agents
Timothy A. Yap, L. Rhoda Molife, Johann S. de Bono

7. CHFR as a Potential Anticancer Target
Minoru Toyota, Lisa Kashima, Takashi Tokino

8. Antimicrotubule Agents
Miguel A. Villalona-Calero, Larry Schaaf, Robert Turowski

9. Kinesin Motor Inhibitors as Effective Anticancer Drugs
Vasiliki Sarli, Athanassios Giannis

10. Targeting the Spindle Checkpoint in Cancer Chemotherapy
Jungseog Kang, Hongtao Yu

11. Antiproliferation Inhibitors Targeting Aurora Kinases
Kishore Shakalya, Daruka Mahadevan

12. Plks as Novel Targets for Cancer Drug Design
Wei Dai, Yali Yang, Ning Jiang

13. Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?
Brian Gabrielli, Frankie Stevens, Heather Beamish

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: TECHNOLOGY & ENGINEERING / Biomedical TEC059000